Status:
COMPLETED
Efficacy of Diazoxide in Type 1 Diabetes
Lead Sponsor:
Grill, Valdemar, M.D.
Conditions:
Diabetes Mellitus, Type 1
Eligibility:
All Genders
18-40 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to find out if Diazoxide can partly retain insulin production in newly diagnosed type 1 diabetes patients.
Detailed Description
At the time of diagnosis most subjects with type 1 diabetes retain significant endogenous insulin secretion as assessed by C-peptide measurements. Although not sufficient for the needs of the individu...
Eligibility Criteria
Inclusion
- Type 1 diabetes no longer than three months
- Positive antibodies against GAD or IA2
- Age between 18-40 years
- C-peptide \>0.2 nmol/l
Exclusion
- Drug or alcohol abuse
- Severe concomitant disease
- Pregnancy
Key Trial Info
Start Date :
February 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2008
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00131755
Start Date
February 1 2005
End Date
August 1 2008
Last Update
July 18 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Trondheim
Trondheim, Norway, 7006